| 5-FU | 5-Fluorouracil |
| BCSC | Breast cancer stem cell |
| EMT | Epithelial-mesenchymal transition |
| ER | Estrogen receptor |
| FAC | 5-Fluorouracil, doxorubicin, and cyclophosphamide |
| FEC | 5-Fluorouracil, epirubicin, and cyclophosphamide |
| HER2 | Human epidermal growth factor receptor 2 |
| HMEC | Human mammary epithelial cell |
| MEBM | Mammary epithelial basal medium |
| miRNA | microRNA |
| NACT | Neoadjuvant chemotherapy |
| NSCLC | Non-small cell lung cancer |
| PR | Progesterone receptor |
| RWD | Relative wound density |
| TAC | Docetaxel, doxorubicin, and cyclophosphamide |
| TC | Docetaxel and cyclophosphamide |
| TNBC | Triple-negative breast cancer |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.